Effects of intravenous administration of allogenic bone marrow- and adipose tissue-derived mesenchymal stem cells on functional recovery and brain repair markers in experimental ischemic stroke
about
The challenges and promises of allogeneic mesenchymal stem cells for use as a cell-based therapyAdipose tissue-derived stem cells as a therapeutic tool for cardiovascular diseaseCell-based therapy for ischemic strokeFate of graft cells: what should be clarified for development of mesenchymal stem cell therapy for ischemic stroke?Human adipose-derived stem cells partially rescue the stroke syndromes by promoting spatial learning and memory in mouse middle cerebral artery occlusion model.New therapy of skin repair combining adipose-derived mesenchymal stem cells with sodium carboxymethylcellulose scaffold in a pre-clinical rat modelNeurorestorative therapy for strokeBone marrow stromal cells promote neuromotor functional recovery, via upregulation of neurotrophic factors and synapse proteins following traumatic brain injury in ratsMesenchymal stem cells exert anti-proliferative effect on lipopolysaccharide-stimulated BV2 microglia by reducing tumour necrosis factor-α levelsEfficient In vitro labeling rabbit bone marrow-derived mesenchymal stem cells with SPIO and differentiating into neural-like cells.Bone marrow mesenchymal stem cells overexpressing human basic fibroblast growth factor increase vasculogenesis in ischemic ratsEffects of bone marrow-derived mesenchymal stem cells on the axonal outgrowth through activation of PI3K/AKT signaling in primary cortical neurons followed oxygen-glucose deprivation injury.White matter injury restoration after stem cell administration in subcortical ischemic stroke.Mesenchymal Stromal Cells Promote Axonal Outgrowth Alone and Synergistically with Astrocytes via tPANeuroprotection and immunomodulation by xenografted human mesenchymal stem cells following spinal cord ventral root avulsionApplying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper.Astroglial Activation by an Enriched Environment after Transplantation of Mesenchymal Stem Cells Enhances Angiogenesis after Hypoxic-Ischemic Brain Injury.Mesenchymal stem cells and their chondrogenic differentiated and dedifferentiated progeny express chemokine receptor CCR9 and chemotactically migrate toward CCL25 or serum.The role of astrocytes in mediating exogenous cell-based restorative therapy for strokeGlial progenitor cell-based treatment of the childhood leukodystrophies.Three-dimensional spheroid-cultured mesenchymal stem cells devoid of embolism attenuate brain stroke injury after intra-arterial injection.Use of genetically modified mesenchymal stem cells to treat neurodegenerative diseases.The use of ADSCs as a treatment for chronic stroke.Intranasal delivery of bone marrow-derived mesenchymal stem cells, macrophages, and microglia to the brain in mouse models of Alzheimer's and Parkinson's disease.Applicability of adipose-derived stem cells in type 1 diabetes mellitus.Stem cell transplantation enhances endogenous brain repair after experimental stroke.Adipose tissue-derived mesenchymal stem cells as a strategy to improve recovery after stroke.Stem cell in alternative treatments for brain tumors: potential for gene delivery.Current developments in cell- and biomaterial-based approaches for stroke repair.Intravenous infusion of human bone marrow mesenchymal stromal cells promotes functional recovery and neuroplasticity after ischemic stroke in mice.Translation, but not transfection limits clinically relevant, exogenous mRNA based induction of alpha-4 integrin expression on human mesenchymal stem cells.Transplantation of bone marrow-derived mesenchymal stem cells (BMSCs) improves brain ischemia-induced pulmonary injury in rats associated to TNF-α expression.Bone marrow stromal cell therapy for ischemic stroke: A meta-analysis of randomized control animal trials.Stem Cell-Based Therapies for Ischemic Stroke: Preclinical Results and the Potential of Imaging-Assisted Evaluation of Donor Cell Fate and Mechanisms of Brain Regeneration.Therapeutic Effect of Ligustilide-Stimulated Adipose-Derived Stem Cells in a Mouse Thromboembolic Stroke Model.Stem cell therapies in age-related neurodegenerative diseases and stroke.Concise Review: Innate and Adaptive Immune Recognition of Allogeneic and Xenogeneic Cell Transplants in the Central Nervous System.Therapeutic angiogenesis of adipose-derived stem cells for ischemic diseases.In vivo IL13-primed macrophages contribute to reduced alloantigen-specific T cell activation and prolong immunological survival of allogeneic mesenchymal stem cell implants.Functional recovery after acute intravenous administration of human umbilical cord mesenchymal stem cells in rats with cerebral ischemia-reperfusion injury
P2860
Q26775933-86ED030C-E805-4684-B0CC-888E86FB0F68Q26795749-11436C5D-F5B3-42A3-BB46-DA8369711CB7Q26827499-42B9C9BA-8CAB-4E5A-92C6-DAD5FB799334Q27692601-B33C5DCE-F06C-4072-B928-6809480ACD90Q30652876-4749BE17-3D22-4D72-BFFD-46B1BD1E87B6Q33560296-30C0AA34-CE8A-44A3-A89C-1590730FEF3EQ33813333-78E57D8C-8A93-416E-9E99-CA7FB48EE8BDQ33827955-457C618A-4D44-431E-9178-BE8A87C3BDCBQ34144015-A84D24E0-B01E-4BF5-9885-0BE83CB1B64CQ34263304-D9797EC3-AFCA-4FD7-A1A2-89974D3FB496Q34272428-5DB78BDB-0C8C-41D9-BA23-61642FC3AECBQ35050306-2948F403-83A4-4D66-9EC9-59C338D1AF69Q35885598-6755280E-5D42-481A-89E9-E5B57CBD1EF6Q36222296-BC87104C-F45C-481B-B38D-C60E26EFAE45Q36262326-14B9355E-DE80-4285-A528-C8C8D9BE7BF3Q36422761-0DED8012-996C-4867-821F-A550ECB38D8BQ37286618-A17B8192-BDE4-48F7-A01E-8ABB5349ED99Q37372324-2E676421-473B-4256-B982-EC1D1790D0A0Q37627332-82D3B44E-E085-46DF-8456-2F69DB6A1CD9Q37684345-5A253A2B-FAD7-4E39-BF1E-54DFE7CCD449Q37719084-0A35021A-7763-48AE-9507-888830784DD1Q38181868-09EC86F7-EA0F-4791-BEB4-B1AA8FE69AE8Q38210871-BCF0B7FC-7030-4A47-9253-CD0AE1DC61B5Q38303586-E3744DC9-4088-45E7-99B3-10EA580FC13AQ38332629-9AD1825E-4B25-4245-B9CD-2B67A3FA1D42Q38369063-A6D2F561-C13E-464F-8340-C93BF9EAEC24Q38469989-06FBDC52-758F-4F00-B1CD-56F67F5BD306Q38521752-104DFEFB-F62E-4DFC-BD03-3DB46F03AEE0Q38595322-4C4CE290-3943-4AF4-8184-6C0B79B13095Q38650671-21B4EE67-5070-47A6-A4AB-CC019893A131Q38691354-715BE662-D225-453F-A061-7BDFA1F97D2DQ38716282-6355EDE5-DFA9-4D68-90C8-110215600070Q38802867-7B5615E2-5772-46DF-A8C1-A0009C7A9E16Q38903653-C48327F4-95A1-44C8-A0B4-1D56A160EE23Q38918620-0A80D319-26DF-4CCD-BF70-721957026D2EQ39017141-E5143A7D-EE9C-4770-95D0-F3B512396923Q39154189-86977E58-89C5-4E00-9248-C0CBDE5506CDQ39352561-EF84A93C-A8BC-4514-9AAE-B08571AA7EACQ39908369-C16DB326-1A17-433A-AC0C-7DAE4D0805D4Q40562142-DEFEF755-8EBF-4773-BBC5-3164D7A3F5FF
P2860
Effects of intravenous administration of allogenic bone marrow- and adipose tissue-derived mesenchymal stem cells on functional recovery and brain repair markers in experimental ischemic stroke
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Effects of intravenous adminis ...... n experimental ischemic stroke
@en
type
label
Effects of intravenous adminis ...... n experimental ischemic stroke
@en
prefLabel
Effects of intravenous adminis ...... n experimental ischemic stroke
@en
P2093
P2860
P50
P356
P1476
Effects of intravenous adminis ...... n experimental ischemic stroke
@en
P2093
Berta Rodríguez-Frutos
Jaime Ramos-Cejudo
M Teresa Vallejo-Cremades
María Gutiérrez-Fernández
P2860
P2888
P356
10.1186/SCRT159
P577
2013-01-28T00:00:00Z
P5875
P6179
1009913598